Clinton Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,324
Closed -$2M 475
2017
Q4
$2M Buy
+5,324
New +$2.16M 0.18% 179
2016
Q4
Sell
-16,499
Closed -$6.63M 967
2016
Q3
$6.63M Buy
16,499
+13,733
+496% +$5.51M 0.31% 86
2016
Q2
$966K Sell
2,766
-5,263
-66% -$2.03M 0.04% 491
2016
Q1
$2.89M Buy
8,029
+5,220
+186% +$2.15M 0.17% 174
2015
Q4
$1.52M Buy
2,809
+2,304
+456% +$1.25M 0.12% 260
2015
Q3
$235K Buy
+505
New +$271K 0.02% 597
2015
Q2
Sell
-2,051
Closed -$926K 682
2015
Q1
$926K Buy
+2,051
New +$869K 0.24% 120
2014
Q2
Sell
-722
Closed -$217K 407
2014
Q1
$217K Sell
722
-490
-40% -$151K 0.08% 308
2013
Q4
$334K Sell
1,212
-355
-23% -$102K 0.11% 219
2013
Q3
$490K Buy
+1,567
New +$412K 0.15% 188

Other funds holding REGN